Bristol Myers Squibb Co. (BMY)

56.00 +0.24 (+0.42%) USD  |  NYSE  |  Jan 13, 13:49
More

Bristol Myers Squibb Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Gilead Sciences, Inc. --
Johnson & Johnson --
Eli Lilly & Co. --
Regeneron Pharmaceuticals, Inc. Upgrade